Pipazethate is a small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication. Its therapeutic use is listed as cough suppressants. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include Theratuss and Selvigon. Its PubChem CID is 22425.
Pipazethate
| CAS No | 2167-85-3 |
|---|---|
| Molecular Formula | C21H25N3O3S |
| Molecular Weight | 399.5 g/mol |
| Synonyms | 2-(2-piperidin-1-ylethoxy)ethyl pyrido[3,2-b][1,4]benzothiazine-10-carboxylate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Pipazethate is a small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication. Its therapeutic use is listed as cough suppressants.
The listed CAS number is 2167-85-3.
The listed molecular formula is C21H25N3O3S.
The listed molecular weight is 399.5 g/mol.
2-(2-piperidin-1-ylethoxy)ethyl pyrido[3,2-b][1,4]benzothiazine-10-carboxylate.
The source lists Theratuss and Selvigon.